Furthermore, the expression of CAF biomarkers, including VIM, FAP, α‐SMA and NG2, was notably higher in the diffuse type compared to the intestinal type (Figure S1E), with elevated FAP expression being specifically associated with a poorer prognosis in diffuse type GC cases (Figure S1F). This evidence concerns the gene FAP and gastric cancer.